http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2117297-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a84d60e2bcc952470217ab46a8120604 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72e2a023c558b51d973e979033b70490 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
filingDate | 1996-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1998-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120971608efb3db2ab363f4f0f31a77d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45790007b8d75969cf8c15dfe5968ee |
publicationDate | 1998-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2117297-C1 |
titleOfInvention | Method of assay of microcirculatory type hemorrhagic diathesis in latent period |
abstract | FIELD: medicine, ophthalmology. SUBSTANCE: method involves determination of aggregation of platelets with adenosine diphosphate disodium salt and with thrombin and plasma blood fibronectin concentration after precipitation of platelet aggregates. Latent period of hemorrhagic diathesis is diagnosed at normal aggregation response of platelets to adenosine diphosphate disodium salt and the absence of response to thrombin and at concentration of fibronectin above 500 mcg/ml. EFFECT: improved method of diagnosis. 2 tbl, 2 ex |
priorityDate | 1996-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.